Effects of Gravidity on Atherogenic Indices in Normotensive and Hypertensive Second Trimester Pregnant Women
Journal of Advances in Biology & Biotechnology,
Page 50-57
DOI:
10.9734/jabb/2022/v25i430278
Abstract
Background: Pregnancy results in certain physiological and metabolic changes that results to shift in certain biochemical markers and could even result in hypertension in some women thus predisposing them to risk of cardiovascular disease. While this is true, some women express these predisposing risk factors in subsequent pregnancies. Therefore, it may be a significant contribution to understand the dynamics of artherogenic indices with increasing number of pregnancies.
Aim: The goal of the study was aimed to assess gravidity effect on artherogenic indices in both normotensive and hypertensive second-trimester pregnant women.
Materials and Methods: At Rivers State University Teaching Hospital, a cross-sectional study was carried out with 100 pregnant women. The consenting patients who met the inclusion criteria were classified into two groups: normotensive (50 normotensive pregnant women in their second trimester) and hypertensive (50 hypertensive pregnant women in their second trimester) (HPW2T). The participants were subsequently split into three subgroups depending on gravidity: primigravida (no of pregnancy=1), multigravida (no of pregnancies>1), and grand multigravida (no of pregnancies≥5). For the assessment of TC, TG, HDL, and LDL, fasting blood samples were taken using the venepuncture technique. Mathematically, artheriogenic indices (AIP, CR-I, CR-II, AC, and APoB/APoA1) were calculated. At a P-value>0.05, the data was examined using ANOVA and the Tukey comparison test.
Results: There was no significant difference in artheriogenic indices between the gravidity groups in the normotensive group, with a P-value>0.05, which was also the cases among those in the hypertensive group.
Conclusion: The study has shown that gravidity does not have any effect on artheriogenic indices among normotensive and hypertensive pregnant women in the second trimester in Rivers State University Teaching Hospital.
Keywords:
- Normotensive
- hypertensive
- artheriogenic
- pregnancy
- second trimester
How to Cite
References
Burdorf S, Bhattacharjee J, Bhatnagar MK, & Tyagi S. Atherogenic index of plasma, Castelli risk index and atherogenic coefficient- new parameters in assessing cardiovascular risk. Int J Pharm Bio Sci. 2012;3:359–64.
Freeman WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical Chemistry. 2009;18:499-502.
Huda MM, Leung TM, Zhou L, Abu- Merhi S. Regulating intestinal function to reduce Atherogenic Lipoproteins. Clinical Lipidology. 2009;8(4):481-490.
Seegers DM, Shdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? American Journal of Obstetrics and Gynecology. 2010;182:589-594.
Hromadnikova I, Kotlabova K, Hympanova L, Krofta L. Cardiovascular and cerebrovascular disease associated microRNAs are dysregulated in placental tissues affected with gestational hypertension, preeclampsia and intrauterine growth restriction. Public library of Science. 2015; 10(9):e0138383.
Khan F, Belch JJF, Macleod M, Mires G. Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops. Hypertension. 2006;46;1123-1128.
Miko E, Meggyes M, Bogar B, Schmitz N, Barakonyi A, Vamaggy A. Involvement of galectin-9/Tim-3 pathway in the systemic inflammatory response in early-onset preeclampsia.Public Library of Science. 2013;8(8):e71811.
Millan J, Pinto X, Munoz A, Zuniga M, Rubies-Prat J, Pallardo LF. Lipoprotein ratios: Physiological Significance and clinical usefulness in cardiovascular
prevention. Vascular Health and Risk Management. 2009;5:757–65.
Bafna A, Maheshwari RS, Ved RK, Sarkar PD, Batham AR. Study of Atherogenic Indices In Nephrotic Syndrome. International Journal of Biological and Medical Research. 2012; 3(3):2257- 60.
Dobiasova M, Frohlich J, Sedova M, Cheung MC, Brown BG. Cholesterol Esterification and Atherogenic Index of Plasma correlate with Lipoprotein size
and findings on Coronary Angiography. Journal of Lipid Research. 2011;52(3):566–71.
Deric M, Kojic-Damjanov S, Cabarkapa V, Eremic N. Biochemical Markers of
Atherosclerosis. Journal of Medical Biology. 2008;27(2):148–53.
Catherine I, Biambo KG, Nyebuchi J, Fyneface AC, Goodnews N. Evaluation of Nutrient Composition in Breast Milk of Breast Feeding Mothers in Urban and Sub-urban Subjects in Rivers State. Asian Journal of Pediatric Research. 2021 ;7(2):39-44.
Faith D, Kalaotaji GB, Nyebuchi J, Chikadibia FA, Felix EK. Comparative study of heavy metals in breast milk of breast feeding mothers in urban and sub-urban subjects in Rivers state. Journal of Applied Life Sciences International. 2021;28(8):31-36.
Oladapo- Akinfolarin TT, Bartimeaus ES, Nwachukwu EO, Nduka N. Assessment of C-reactive protein levels in normotensive and hypertensive pregnant subjects in Port Harcourt, Nigeria. World Journal of Pharmaceutical and Medical Research. 2017;3(10):292-296.
Oladapo- Akinfolarin TT, Bartimeaus ES, Nwachukwu EO, Nduka N. Assessment lipoprotein levels in normotensive and hypertensive pregnant women in Port Harcourt, Nigeria. American Journal of Biomedical Sciences. 2018;10(1):18- 27.
Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic Determination of Total Serum Cholesterol. Clinical Chemistry. 1974;20 (4):470-475.
Tietz NW. Laboratory Methods. In: Fundamentals of Clinical Chemistry, 3rd Edition, W.B. Saunders Company, Philadelphia. 1987;927-962
Fraser CG, Hearne CR. Assessment of colorimetric enzymatic determination of triglyceride, by manual and centrifugal analyzer techniques, and comparison with a CDC standardized method. Clinical Biochemistry. 1981;14 (1):28-31.
Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clinical Chemistry, 1972;18:499- 502.
World Health Organization. Non-communicable diseases. Cardiovascular Diseases (CVDs). Last accessed on 2014 may 10, at 9:40 pm;2014.
Available:http//www.who.int/mediacentre/factsheet s/fs317/en/h.
Serrano NC, Casas JP. Lipid Profile, Plasma Apolipoproteins and Preeclampsia Risk in the Gen PE Case Control Study. Atherosclerosis. 2018;276:189– 194.
Meenakshi S, Mauchuimi SP, Anindita P. A Study on Atherogenic Indices of Pregnancy Induced Hypertension Patients as Compared to Normal Pregnant Women. Journal of Clinical and Diagnostic Research. 2015;9(7):BC05 – BC08.
Aksonova A, Ventskovskaya IR, Yuzvenko T. Atherogenic Parameters and Cardiac Indices in Prognostication of Development of Preeclampsia and its Cardio-metabolic Consequences, Eureka. Health Sciences. 2016;21303:2504 – 5679.
Agatisa PK, Ness RB, Roberts JM, Costantino JP, Kuller LH, McLaughlin MK. Impairment of endothelial function in women with a history of pre-eclampsia: an indicator of cardiovascular risk. American Journal of Physiology and Heart Circulatory Physiology. 2004;286:1389-1393.
Dutta DC. (7th ed). Chapter: Hypertensive disorders in pregnancy Textbook of Obstetrics. Kolkata: New Central Book Agency. 2011;219-40.
Negre-salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R. Pathological aspects of lipid peroxidation. Free Radical Research. 2010;44(10):1125-71.
-
Abstract View: 66 times
PDF Download: 24 times
